Hostname: page-component-68945f75b7-wph62 Total loading time: 0 Render date: 2024-08-06T01:05:21.818Z Has data issue: false hasContentIssue false
  • English
  • Français

Genetic Diagnosis: Implications for Medical Practice

Published online by Cambridge University Press:  10 March 2009

David Blumenthal  and
Richard Zeckhauser
David Blumenthal
Affiliation:
Brigham and Womens's Hospital and Harvard Medical School
Richard Zeckhauser
Affiliation:
Harvard University
Get access Rights & Permissions [Opens in a new window]

Extract

Genetic diagnostic techniques increasingly permit the detection of predisposition to illness long before the onset of the disease process itself. Medicine is on the verge of becoming a predictive science as well as a diagnostic and therapeutic one. Genetic diagnosis could have profound effects on many aspects of our health care system, including the prestige and effectiveness of preventive medicine, the competitive behavior of health care organizations and insurance companies, access to private health insurance, the ability of primary care physicians to serve as gatekeepers, and other matters. This article examines the range of potential effects of the new genetic diagnostics on the organization and financing of health care. For purposes of illustration the authors examine in detail the possible consequences of genetic tests for predisposition to two diseases: Reye's Syndrome and lung cancer in smokers.

Type
General Essays
Information
International Journal of Technology Assessment in Health Care , Volume 5 , Issue 4 , October 1989 , pp. 579 - 600
Copyright
Copyright © Cambridge University Press 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Altman, S. H. & Blendon, R. (eds.). New technology: the culprit behind health care costs? Washington, DC: U.S. Department of Health, Education and Welfare, Public Health Service, Office of Health Research Statistics and Technology, No. (PHS) 79–3216, 1979.Google Scholar
Banta, H. D., Behney, C. J. & Willems, J. S.Toward rational technology in medicine. New York: Springer, 1981.Google ScholarPubMed
Barbacid, M.Oncogenes and human cancer: Cause or consequence. Carcinogenesis, 1986, 7, 1037–42.CrossRefGoogle ScholarPubMed
Beck, E. B., Blaichman, S., Scriver, C. R. et al. , Advocacy and compliance in genetic screening. New England Journal of Medicine, 1974, 291, 1166–71.CrossRefGoogle ScholarPubMed
Blumenthal, D.The social responsibility of physicians in a changing health care system. Inquiry, 1986, 23, 268–74.Google Scholar
Blumenthal, D., Bentkover, J., Musacchio, R. et al. , Physician services for the uninsured: Who cares, how much and why? 1987. Unpublished.Google Scholar
Blumenthal, D., Feldman, P. & Zeckhauser, R. J. Misuse of technology: A symptom, not the disease. In McNeil, B. J. & Cravaiho, E. G. (eds.), Critical issues in medical technology. Boston, MA: Auburn House, 1982, 163–74.Google Scholar
Blumenthal, D. & Zeckhauser, R. J. The artificial heart as an economic issue. In Shaw, M. W. (ed.), After Barney Clark – Reflections on the Utah artificial heart program. Austin, TX: University of Texas Press, 1984, 149–67.Google Scholar
Califano, J. A.America's health care revolution: Who lives? Who dies? Who pays? New York: Random House, 1986.Google ScholarPubMed
Cannon-Albright, , Lisa, A. et al. , Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. New England Journal of Medicine, 1988, 319, 533–36.CrossRefGoogle ScholarPubMed
Conneally, P. M.Huntington disease: Genetics and epidemiology. American Journal of Human Genetics, 1984, 36, 506–26.Google ScholarPubMed
Craufurd, D. I. O. & Harris, R.Ethics of predictive testing for Huntington's chorea: The need for more information. British Medical Journal, 1986, 293, 249–51.CrossRefGoogle ScholarPubMed
Danzon, P. M., Manning, W. G. & Marquis, S. M.Factors affecting laboratory test use and prices. Health Care Financing Review, 1984, 5(4), 23–32.Google ScholarPubMed
Eddy, D. M. & Billings, J.The quality of medical evidence. Health Affairs, 1988, 7, 19–32.CrossRefGoogle ScholarPubMed
Egeland, J. A., Gerhard, D. S., Pauls, D. L. et al. , Bipolar affective disorders linked to DNA markers on chromosome II. Nature, 1987, 325, 783–87.CrossRefGoogle Scholar
Epstein, A. M., Begg, C. B. & McNeil, B. J.The use of ambulatory testing in prepaid and fee for service group practice settings. Clinical Research, 1985, 33, 249A.Google Scholar
Epstein, A. M., Kroch, S. J. & McNeil, B. J.Office laboratory tests, perceptions of profitability. Medical Care, 1984, 22, 160–66.CrossRefGoogle ScholarPubMed
Farley, P. J.Who are the underinsured? Milbank Memorial Fund Quarterly/Health and Society, 1985, 63, 476–503.CrossRefGoogle ScholarPubMed
Fraser, F. C.Genetics as health care service. New England Journal of Medicine, 1976, 295, 486–88.CrossRefGoogle ScholarPubMed
Friend, S. H., Bernards, R., Snezna, R. et al. , A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature, 1986, 323, 643–46.CrossRefGoogle ScholarPubMed
Garrison, L. P. & Wilensky, G. R.Cost containment and incentives for technology. Health Affairs, 1986, 5(2), 47–58.CrossRefGoogle ScholarPubMed
Gruber, L. R., Shadle, M. & Pollich, C. L.From movement to industry: The growth of HMOs. Health Affairs, 1988, 7, 197–208.CrossRefGoogle ScholarPubMed
Harris, C. C.Tobacco smoke and lung disease: Who is susceptible? Annals of Internal Medicine, 1986, 105, 607–09.CrossRefGoogle ScholarPubMed
Headings, V. E.Educating physicians in the art of counseling for genetic disorders. Perspectives in Biology and Medicine, 1982, 25, 428–35.CrossRefGoogle ScholarPubMed
Heston, L. L., Mastri, A. R., Anderson, E. et al. , Dementia of the Alzheimer type: Clinical genetics, natural history and associated conditions. Archives of General Psychiatry, 1981, 38, 1085–90.CrossRefGoogle ScholarPubMed
Hillman, B. J., Neu, C. R., Winkler, J. D. et al. , Diffusion of magnetic resonance imaging into clinical practice. Santa Monica, CA: Rand Corporation, Rand Publication Series R-3392-HHS, 1986.Google Scholar
Holtzman, N. A.Recombinant DNA technology, genetic tests, and public policy. American Journal of Human Genetics, 1986, 42, 624–32.Google Scholar
Holtzman, N. A. & Hewitt, M.Applications of biotechnology to tests for human genetics disorders. Washington, DC: Office of Technology Assessment background paper, 07 1–2, 1986.Google Scholar
Hurwitz, E. S., Barrett, M. J., Bregman, D. et al. , Public health service study on Reye's syndrome and medications. New England Journal of Medicine, 1985, 313, 849–57.CrossRefGoogle Scholar
Knoppers, B. M.Genetic information and the law: Constraints, liability and rights. Canadian Medical Association Journal, 1986, 135, 1257–59.Google ScholarPubMed
Kolata, G.Genetic screening raises questions for employees and insurers. Science, 1986, 232, 317–19.CrossRefGoogle Scholar
Lamport, A. T.Presymptomatic testing for Huntington's chorea: Ethical and legal issues. American Journal of Medical Genetics, 1987, 26, 307–14.CrossRefGoogle ScholarPubMed
Lynch, H. T., Kimberling, W. J., Markvicka, S. E. et al. , Genetics and smoking-associated cancers: A study of 485 families. Cancer, 1986, 57, 1640–46.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
Manning, W. G., Liebowtiz, A., Goldberg, G. A. et al. , A controlled trial of the effect of a prepaid group practice on use of services. New England Journal of Medicine, 1984, 310, 1505–10.CrossRefGoogle ScholarPubMed
Martin, J. B.Genetic linkage in neurologic diseases. New England Journal of Medicine, 1987, 316, 1018–19.CrossRefGoogle ScholarPubMed
Maxwell, J. H., Blumenthal, D. & Sapolsky, H. M.Obstacles to developing and using health care technology: The case of the artificial heart. International Journal of Technology Assessment in Health Care, 1986, 2, 411–24.CrossRefGoogle ScholarPubMed
McCormack, M. K.Screening for genetic traits and diseases. American Family Physician, 1981, 24, 153–66.Google ScholarPubMed
Meister, S. B., Shepard, D. S. & Zeckhauser, R. J. Cost-effectiveness of prenatal screening for neural tube defects. In Nightingale, E. O. & Meister, S. B. (eds.), Prenatal screening, policies, and values: The example of neural tube defects. Cambridge, MA: Harvard University Press, 1987.Google Scholar
Merz, B.Geneticists ponder ethical implications of screening. Journal of the American Medical Association, 1985, 254, 3160.CrossRefGoogle ScholarPubMed
Myers, L. P., Eisenberg, J. M. & Pauly, M. V.Physicians' payment and their prescription of laboratory tests. Unpublished paper for the U.S. Congress Office of Technology Assessment, 09 1985.Google Scholar
Nightingale, E. O. & Meister, S. B. (eds.) Prenatal screening, policies and values: The examples of neural tube defects. Cambridge, MA: Harvard University Press, 1987.Google Scholar
Oetting, L. A. & Steele, M. W.A controlled retrospective follow-up study of the impact of genetic couseling on prenatal reproduction following the birth of a Down syndrome child. Clinical Genetics, 1982, 21, 7–13.CrossRefGoogle Scholar
Olson, M.The logic of collective action. Cambridge, MA: Harvard University Press, 1965.CrossRefGoogle Scholar
Perera, F. P. & Weinstein, I. B.Molecular epidemiology and carcinogen-DNA addent detection: New approaches to studies of human cancer causation. Journal of Chronic Diseases, 1982, 35, 581–600.CrossRefGoogle Scholar
Pinsky, F. P., Hurwitz, E. S., Schenberger, L. B. & Gunn, W. J.Reye's syndrome and aspirin: Evidence of a dose-response effect. Journal of the American Medical Association, 1988, 260, 657–61.CrossRefGoogle ScholarPubMed
Read, J. L., Stern, R. S., Thibodeau, L. A. et al. , Variation in antenatal testing over time and between clinical settings. Journal of the American Medical Association, 1983, 249, 1605–09.CrossRefGoogle Scholar
Rogers, M. F., Schonberger, L. B., Hurwitz, E. S. et al. , National Reye's syndrome surveillance, 1982. Pediatrics, 1985, 75, 260–64.CrossRefGoogle Scholar
Roghmann, K. J., Doherty, R., Robinson, J. L. et al. , The selective utilization of prenatal genetic diagnosis. Medical Care, 1983, 21, 1111–25.CrossRefGoogle ScholarPubMed
Salmon, D. J., Clark, G. M., Wong, S. G. et al. , Human breast cancer: Correlation of relapse and survival with amplification of the HER-Z/neu oncogene. Science, 1987, 235, 177–82.CrossRefGoogle Scholar
Schlesinger, M., Blumenthal, D. & Schlesinger, E.Profits under pressure: The economic performance of investor-owned and non-profit health maintenance organizations. Medical Care, 1986, 24, 615–27.CrossRefGoogle ScholarPubMed
Schmeck, H. M. JrBurst of discoveries reveals genetic basis for many diseases. New York Times, 03 31, 1987, p. Cl.Google Scholar
Schmeck, H. M. Jr Young science of cancer genes begins to yield practical applications. New York Times, 10 6, 1987, p. Cl.Google Scholar
Sepe, S. J., Marks, J. S., Oakley, G. P. et al. , Genetics services in the United States. Journal of the American Medical Association, 1982, 248, 1733–35.CrossRefGoogle ScholarPubMed
Shaw, M. W.Testing for the Huntington gene: A right to know, a right not to know, or a duty to know. American Journal of Medical Genetics, 1987, 26, 243–46.CrossRefGoogle ScholarPubMed
Skillrud, D. M., Offord, N. P. & Miller, R. D.Higher risk of lung cancer in chronic obstructive pulmonary disease: A prospective matched controlled study. Annals of Internal Medicine, 1986, 105, 503–07.CrossRefGoogle ScholarPubMed
Smurl, J. F. & Weaver, D. D.Presymptomatic testing for Huntington's chorea: Guidelines for moral and social accountability. American Journal of Medical Genetics, 1987, 26, 247–57.CrossRefGoogle ScholarPubMed
Tarlov, A. R.HMO enrollment growth and physicians: The third compartment. Health Affairs, 1986, 5(1), 23–35.CrossRefGoogle ScholarPubMed
U.S. Congress, Office of Technology Assessment. Diagnosis related groups (DRGs) and the Medicare program: Implications for medical technology – a technical memorandum. Washington, DC: U.S. Congress, Office of Technology Assessment, OTA-TM-H-17, 07, 1983.Google Scholar
U.S. Congress, Office of Technology Assessment. Human gene therapy background paper. Washington, DC: U.S. Government Printing Office, OTA-BP-BA-32, 12, 1984.Google Scholar
U.S. Congress, Office of Technology Assessment. Medical technology and costs of the Medicare program. Washington, DC: U.S. Government.Printing Office, OTA-H-227, 07, 1984.Google Scholar
U.S. Congress, Office of Technology Assessment. Medical technology under proposals to increase competition in health care. Washington, DC: U.S. Government Printing Office, 10, 1982.Google Scholar
Waldman, R. J., Hall, W. N., McGee, H. et al. , Aspirin as a risk factor in Reye's syndrome. Journal of the American Medical Association, 1982, 247, 3089–94.CrossRefGoogle ScholarPubMed
Wertz, D. C. & Sorensen, J. R.Contraceptive use and efficiency in a genetically counselled population. Social Biology, 1983, 30, 328–34.Google Scholar
White, R.The search for the cystic fibrosis gene. Science, 1986, 234, 1054–55.CrossRefGoogle ScholarPubMed
Wilensky, G. R. & Rossiter, L. EThe relative importance of physician-induced demand in the demand for medical care. Milbank Memorial Fund Quarterly/Health and Society, 1983, 61, 252–77.CrossRefGoogle ScholarPubMed
Zeckhauser, R. J. & Shepard, D.Where now for saving lives. Law and Contemporary Problems, 1976, 40(4), 5–45.CrossRefGoogle Scholar